Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer
Prostate cancer (PC) is one of the most common cancers and is a leading cause of death. Its initial growth is dependent on androgens; most patients show an initial response to hormonal therapy but will experience disease progression when PC becomes resistant to castration. In 2004, two key randomize...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2013-01-01
|
| coleção: | Clinical Medicine Insights: Oncology |
| Acesso em linha: | https://doi.org/10.4137/CMO.S7256 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|